✦ LIBER ✦

Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer With EGFR Mutations

✍ Scribed by Moran, T.; Sequist, L. V.

Book ID: 115538203
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 202 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2012.43.1858

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Takayuki Fukui; Tetsuya Mitsudomi 📂 Article 📅 2008 🏛 Springer Japan 🌐 Japanese ⚖ 265 KB

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis

✍ Xiao-Hang Zhang; Cheng Li; Chen-Fei Dai; Bao-Sen Zhou 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 203 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer : Impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors

✍ Victor Cohen; Jason S. Agulnik; Celina Ang; Goulnar Kasymjanova; Gerald Batist; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) kinase domain are associated with sensitivity to EGFR‐tyrosine kinase inhibitors (EGFR‐TKI) in patients with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors tested the possibility that nucleoti

Mutations of the epidermal growth factor

Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer

✍ Tetsuya Mitsudomi; Yasushi Yatabe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB